Back

CME Outfitters, LLC

  • Calcitonin
  • Glucagon-Like Peptide 1
  • Insulin
  • Islet Amyloid Polypeptide
  • Obesity

Riding the Waves of Obesity Science – Amylin at a Glance: A Mechanistic Map of a Systems Satiety Signal

Obesity care is moving quickly past the one-drug, one-pathway era. Current therapies have reshaped what treatment can achieve, yet responses vary widely and not every patient tolerates or responds to them, leaving clinicians searching for the next complementary mechanism. Amylin is among the most compelling. A hormone most clinicians last encountered as insulin’s co secreted partner, amylin is now understood as a systems level satiety signal with distinctive receptor biology and promise as monotherapy or in combination strategies. For many obesity medicine clinicians, though, that knowledge still stops at “co secreted with insulin,” a gap that makes it hard to interpret the growing body of investigational amylin data, distinguish selective amylin analogs from dual amylin and calcitonin receptor agonists (DACRAs), or judge where these agents fit within chronic, multi pathway disease management. In this second CMEO Snack of the Riding the Waves of Obesity Science series, amylin researcher Matthew R. Hayes, PhD joins moderator Robert F. Kushner, MD for a focused, practical conversation that turns amylin from a half remembered footnote into working clinical knowledge; what amylin actually does, how its calcitonin receptor/receptor activity-modifying protein (RAMP) biology shapes today’s drug classes, and why its signal complements rather than duplicates glucagon-like peptide-1 (GLP 1). Designed for physicians, nurse practitioners, physician associates, and pharmacists across obesity medicine, endocrinology, primary care, and cardiometabolic practice, this activity will help you read the emerging science with a sharper eye and be ready for the amylin based therapies that may be on the horizon.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

Yes

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Aug 21, 2026
  • Last day to claim credit
    Aug 22, 2027 10 months left